Allied Market Research published a report, titled, โGlobal Sepsis Diagnostics Market by Product (Blood Culture Media, Instruments, Assay kits & Reagents, Software), by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), by Method (Conventional Diagnostics, Automated Diagnostics), by Usability (Laboratory Testing, Point-of-care Testing), by Pathogen (Bacterial Sepsis, Fungal Sepsis, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030.โ According to the report published by Allied Market Research, the global sepsis diagnostics market was estimated at USD 569.49 million in 2020 and is Anticipated to hit USD 1.2 billion by 2030, registering a CAGR of 7.8% from 2021 to 2030.
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Rise in government funding for sepsis-related research activities and increase in the prevalence of infectious diseases drive the growth of the global sepsis diagnostic market. On the other hand, high costs associated with automated diagnostics devices impede the growth to some extent. However, developments in rapid diagnosis/point-of-care) techniques for early sepsis diagnostics are expected to create lucrative opportunities in the industry.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/4255 ย ย
๐๐จ๐ฉ ๐๐๐ฉ๐ฌ๐ข๐ฌ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Nanosphere Inc.
- Bruker Corporation
- Abbott Laboratories, Inc.
- Beckman Coulter, Inc.
- Danaher Corporation
- BioMerieux
- T2 Biosystems, Inc.
- Hoffmann-LA Roche Ltd.
๐๐๐ฉ๐ฌ๐ข๐ฌ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By method, the conventional diagnostics segment held the major share in 2020, garnering nearly three-fourths of the global sepsis diagnostic market, due to the cost-effectiveness of conventional diagnostics methods as compared to automated diagnostic practices. The automated diagnostics segment, on the other hand, is projected to cite the fastest CAGR of 8.3% throughout the forecast period.
By product, the blood culture media segment contributed to the lionโs share in 2020, holding nearly two-fifths of the global sepsis diagnostic market. Increase in the number of sepsis case, rise in geriatric population, high incidence of bloodstream infection, and growth in the demand for rapid diagnostic techniques fuel the segment growth. However, the instruments segment is projected to manifest the fastest CAGR of 8.7% from 2021 to 2030.
By region, North America dominated in 2020, garnering nearly half of the global sepsis diagnostic market, due to the presence of highly advanced healthcare system, high adoption of innovative sepsis diagnostics technology, and technological development in the field of sepsis diagnostic. The market across Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 8.9% throughout the forecast period. Growing demand for sepsis diagnostics solutions in countries such as China and India fuels the market growth.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4255
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.